Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Sell
7,476
-2,919
-28% -$727K 0.05% 367
2025
Q4
$2.5M Sell
10,395
-4,571
-31% -$1.17M 0.07% 280
2025
Q3
$4.1M Sell
14,966
-3,724
-20% -$1.02M 0.12% 186
2025
Q2
$4.82M Sell
18,690
-1,159
-6% -$276K 0.15% 162
2025
Q1
$4.44M Buy
19,849
+16,658
+522% +$3.89M 0.15% 153
2024
Q4
$730K Buy
3,191
+9
+0.3% +$2.17K 0.02% 539
2024
Q3
$777K Buy
3,182
+422
+15% +$94.3K 0.02% 534
2024
Q2
$528K Hold
2,760
0.02% 642
2024
Q1
$547K Sell
2,760
-3,070
-53% -$563K 0.02% 623
2023
Q4
$1M Buy
5,830
+556
+11% +$85.4K 0.03% 444
2023
Q3
$780K Sell
5,274
-616
-10% -$111K 0.03% 483
2023
Q2
$1.29M Sell
5,890
-1,950
-25% -$435K 0.05% 369
2023
Q1
$1.72M Sell
7,840
-1,756
-18% -$381K 0.06% 314
2022
Q4
$2M Buy
9,596
+509
+6% +$112K 0.07% 291
2022
Q3
$1.98M Buy
9,087
+44
+0.5% +$10K 0.08% 289
2022
Q2
$1.9M Buy
9,043
+1,097
+14% +$234K 0.07% 326
2022
Q1
$1.93M Sell
7,946
-817
-9% -$198K 0.07% 335
2021
Q4
$2.28M Buy
8,763
+5,145
+142% +$1.34M 0.08% 243
2021
Q3
$954K Sell
3,618
-298
-8% -$81.5K 0.03% 453
2021
Q2
$965K Sell
3,916
-256
-6% -$53.8K 0.03% 484
2021
Q1
$809K Sell
4,172
-63
-1% -$12.6K 0.03% 517
2020
Q4
$900K Sell
4,235
-242
-5% -$48.3K 0.04% 432
2020
Q3
$767K Sell
4,477
-59
-1% -$10.9K 0.04% 419
2020
Q2
$871K Sell
4,536
-2,786
-38% -$456K 0.05% 340
2020
Q1
$1.08M Buy
7,322
+112
+2% +$17.8K 0.06% 295
2019
Q4
$1.12M Buy
+7,210
New +$1.04M 0.05% 345

Other funds holding RMD

Vestcor Inc's RMD Position: Q1 2026 in Review

Vestcor Inc reduced its ResMed (RMD) stake by 28% in Q1 2026, selling an estimated $727K and leaving 7,476 shares worth $1.68M. The position accounts for 0.05% of the portfolio, ranked #367.

Vestcor Inc first reported a position in RMD in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.82M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Vestcor Inc held 7,476 shares of ResMed worth $1.68M as of Q1 2026.
  • Vestcor Inc sold 2,919 ResMed shares in Q1 2026, an estimated $727K.
  • ResMed made up 0.05% of Vestcor Inc's portfolio in Q1 2026, its #367 holding.
  • Vestcor Inc first reported a position in ResMed in Q4 2019 and has held it in 26 quarters since.
  • Vestcor Inc's ResMed position peaked at $4.82M in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.